Engineered cells could help tackle the third most common cancer in Chinese males
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Mar 10, 2015
0
5